[
  {
    "title": "Gilead Helps Put African Nation on Path To Eliminate Hepatitis C",
    "published": 1715089500,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 65.43000030517578,
      "2024-05-07T14:30:00+00:00": 65.56500244140625,
      "2024-05-07T15:30:00+00:00": 65.8812026977539,
      "2024-05-07T16:30:00+00:00": 65.87000274658203,
      "2024-05-07T17:30:00+00:00": 65.88999938964844,
      "2024-05-07T18:30:00+00:00": 65.8550033569336,
      "2024-05-07T19:30:00+00:00": 65.86499786376953
    },
    "sentiment": 0.80910724401474
  },
  {
    "title": "Guild Esports Joins Elite Esports World Cup",
    "published": 1715047200,
    "day_prices": {
      "2024-05-07T13:30:00+00:00": 65.43000030517578,
      "2024-05-07T14:30:00+00:00": 65.56500244140625,
      "2024-05-07T15:30:00+00:00": 65.8812026977539,
      "2024-05-07T16:30:00+00:00": 65.87000274658203,
      "2024-05-07T17:30:00+00:00": 65.88999938964844,
      "2024-05-07T18:30:00+00:00": 65.8550033569336,
      "2024-05-07T19:30:00+00:00": 65.86499786376953
    },
    "sentiment": 0.9058084487915039
  },
  {
    "title": "Bargain Hunting: 7 Stocks Near 52-Week Lows to Buy Before the Bounce Back",
    "published": 1715013543,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 64.79000091552734,
      "2024-05-06T14:30:00+00:00": 64.95210266113281,
      "2024-05-06T15:30:00+00:00": 64.4749984741211,
      "2024-05-06T16:30:00+00:00": 64.5,
      "2024-05-06T17:30:00+00:00": 64.8499984741211,
      "2024-05-06T18:30:00+00:00": 65.13500213623047,
      "2024-05-06T19:30:00+00:00": 65.16999816894531
    },
    "sentiment": 0.9032235145568848
  },
  {
    "title": "Gilead Sciences Unusual Options Activity For May 06",
    "published": 1714962060,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 64.79000091552734,
      "2024-05-06T14:30:00+00:00": 64.95210266113281,
      "2024-05-06T15:30:00+00:00": 64.4749984741211,
      "2024-05-06T16:30:00+00:00": 64.5,
      "2024-05-06T17:30:00+00:00": 64.8499984741211,
      "2024-05-06T18:30:00+00:00": 65.13500213623047,
      "2024-05-06T19:30:00+00:00": 65.16999816894531
    },
    "sentiment": 0.8084583282470703
  },
  {
    "title": "Pharma R&D productivity seen improving for the first time in years - Deloitte",
    "published": 1714790100,
    "day_prices": {},
    "sentiment": 0.9528807997703552
  },
  {
    "title": "Interesting GILD Put And Call Options For June 14th",
    "published": 1714732440,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 65.52999877929688,
      "2024-05-03T14:30:00+00:00": 64.55000305175781,
      "2024-05-03T15:30:00+00:00": 64.48999786376953,
      "2024-05-03T16:30:00+00:00": 64.42990112304688,
      "2024-05-03T17:30:00+00:00": 64.60669708251953,
      "2024-05-03T18:30:00+00:00": 64.66999816894531,
      "2024-05-03T19:30:00+00:00": 64.68000030517578
    },
    "sentiment": 0.9112786650657654
  },
  {
    "title": "Shhh! 3 Secret Biotech Stocks Flying Below Wall Street\u2019s Radar",
    "published": 1714588729,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 65.51000213623047,
      "2024-05-01T14:30:00+00:00": 65.18000030517578,
      "2024-05-01T15:30:00+00:00": 65.72000122070312,
      "2024-05-01T16:30:00+00:00": 65.41999816894531,
      "2024-05-01T17:30:00+00:00": 65.36499786376953,
      "2024-05-01T18:30:00+00:00": 65.11000061035156,
      "2024-05-01T19:30:00+00:00": 65.86000061035156
    },
    "sentiment": 0.8501288890838623
  },
  {
    "title": "Market Whales and Their Recent Bets on GILD Options",
    "published": 1715777280,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 67.94000244140625,
      "2024-05-15T14:30:00+00:00": 67.53500366210938,
      "2024-05-15T15:30:00+00:00": 67.41500091552734,
      "2024-05-15T16:30:00+00:00": 67.6500015258789,
      "2024-05-15T17:30:00+00:00": 67.72000122070312,
      "2024-05-15T18:30:00+00:00": 67.63999938964844,
      "2024-05-15T19:30:00+00:00": 67.33499908447266
    },
    "sentiment": 0.8522631525993347
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds Gilead Sciences",
    "published": 1715761920,
    "day_prices": {
      "2024-05-15T13:30:00+00:00": 67.94000244140625,
      "2024-05-15T14:30:00+00:00": 67.53500366210938,
      "2024-05-15T15:30:00+00:00": 67.41500091552734,
      "2024-05-15T16:30:00+00:00": 67.6500015258789,
      "2024-05-15T17:30:00+00:00": 67.72000122070312,
      "2024-05-15T18:30:00+00:00": 67.63999938964844,
      "2024-05-15T19:30:00+00:00": 67.33499908447266
    },
    "sentiment": 0.9421179890632629
  },
  {
    "title": "Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy",
    "published": 1715695740,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 68.0,
      "2024-05-14T14:30:00+00:00": 67.37000274658203,
      "2024-05-14T15:30:00+00:00": 67.20500183105469,
      "2024-05-14T16:30:00+00:00": 67.20999908447266,
      "2024-05-14T17:30:00+00:00": 67.1500015258789,
      "2024-05-14T18:30:00+00:00": 67.5,
      "2024-05-14T19:30:00+00:00": 67.76000213623047
    },
    "sentiment": 0.9557996392250061
  },
  {
    "title": "Gilead's Kite data at EHA 2024 demonstrate 'positive' patient outcomes",
    "published": 1715678100,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 68.0,
      "2024-05-14T14:30:00+00:00": 67.37000274658203,
      "2024-05-14T15:30:00+00:00": 67.20500183105469,
      "2024-05-14T16:30:00+00:00": 67.20999908447266,
      "2024-05-14T17:30:00+00:00": 67.1500015258789,
      "2024-05-14T18:30:00+00:00": 67.5,
      "2024-05-14T19:30:00+00:00": 67.76000213623047
    },
    "sentiment": 0.9563145637512207
  },
  {
    "title": "Xilio Therapeutics expects cash to fund operations into Q2 of 2025",
    "published": 1715668680,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 68.0,
      "2024-05-14T14:30:00+00:00": 67.37000274658203,
      "2024-05-14T15:30:00+00:00": 67.20500183105469,
      "2024-05-14T16:30:00+00:00": 67.20999908447266,
      "2024-05-14T17:30:00+00:00": 67.1500015258789,
      "2024-05-14T18:30:00+00:00": 67.5,
      "2024-05-14T19:30:00+00:00": 67.76000213623047
    },
    "sentiment": 0.6320071816444397
  },
  {
    "title": "Guild Esports Converts Loan and Appoints New Secretary",
    "published": 1715564580,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 66.19000244140625,
      "2024-05-13T14:30:00+00:00": 66.80000305175781,
      "2024-05-13T15:30:00+00:00": 67.26499938964844,
      "2024-05-13T16:30:00+00:00": 67.01000213623047,
      "2024-05-13T17:30:00+00:00": 67.34429931640625,
      "2024-05-13T18:30:00+00:00": 67.23580169677734,
      "2024-05-13T19:30:00+00:00": 67.31500244140625
    },
    "sentiment": 0.8771644830703735
  },
  {
    "title": "Decoding Gilead Sciences's Options Activity: What's the Big Picture?",
    "published": 1715345820,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 64.72000122070312,
      "2024-05-10T14:30:00+00:00": 65.66999816894531,
      "2024-05-10T15:30:00+00:00": 65.76000213623047,
      "2024-05-10T16:30:00+00:00": 65.77999877929688,
      "2024-05-10T17:30:00+00:00": 66.09500122070312,
      "2024-05-10T18:30:00+00:00": 65.79000091552734,
      "2024-05-10T19:30:00+00:00": 65.92500305175781
    },
    "sentiment": 0.9310535192489624
  },
  {
    "title": "Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program",
    "published": 1715270700,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 65.1500015258789,
      "2024-05-09T14:30:00+00:00": 64.91500091552734,
      "2024-05-09T15:30:00+00:00": 64.83999633789062,
      "2024-05-09T16:30:00+00:00": 64.6500015258789,
      "2024-05-09T17:30:00+00:00": 64.83499908447266,
      "2024-05-09T18:30:00+00:00": 64.79499816894531,
      "2024-05-09T19:30:00+00:00": 64.66120147705078
    },
    "sentiment": 0.9289946556091309
  },
  {
    "title": "Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine",
    "published": 1715233800,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 65.1500015258789,
      "2024-05-09T14:30:00+00:00": 64.91500091552734,
      "2024-05-09T15:30:00+00:00": 64.83999633789062,
      "2024-05-09T16:30:00+00:00": 64.6500015258789,
      "2024-05-09T17:30:00+00:00": 64.83499908447266,
      "2024-05-09T18:30:00+00:00": 64.79499816894531,
      "2024-05-09T19:30:00+00:00": 64.66120147705078
    },
    "sentiment": 0.7897726893424988
  },
  {
    "title": "Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma asset",
    "published": 1715228340,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 65.1500015258789,
      "2024-05-09T14:30:00+00:00": 64.91500091552734,
      "2024-05-09T15:30:00+00:00": 64.83999633789062,
      "2024-05-09T16:30:00+00:00": 64.6500015258789,
      "2024-05-09T17:30:00+00:00": 64.83499908447266,
      "2024-05-09T18:30:00+00:00": 64.79499816894531,
      "2024-05-09T19:30:00+00:00": 64.66120147705078
    },
    "sentiment": 0.7577610015869141
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Scholar Rock Holding (SRRK), Gilead Sciences (GILD)",
    "published": 1716445260,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 67.62999725341797,
      "2024-05-23T14:30:00+00:00": 67.19000244140625,
      "2024-05-23T15:30:00+00:00": 66.75399780273438,
      "2024-05-23T16:30:00+00:00": 66.88999938964844,
      "2024-05-23T17:30:00+00:00": 66.2699966430664,
      "2024-05-23T18:30:00+00:00": 66.12999725341797,
      "2024-05-23T19:30:00+00:00": 66.22989654541016
    },
    "sentiment": 0.5328446626663208
  },
  {
    "title": "Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024",
    "published": 1716381000,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 67.18000030517578,
      "2024-05-22T14:30:00+00:00": 67.69999694824219,
      "2024-05-22T15:30:00+00:00": 67.5199966430664,
      "2024-05-22T16:30:00+00:00": 67.71050262451172,
      "2024-05-22T17:30:00+00:00": 67.84500122070312,
      "2024-05-22T18:30:00+00:00": 67.63999938964844,
      "2024-05-22T19:30:00+00:00": 67.43000030517578
    },
    "sentiment": 0.8820438385009766
  },
  {
    "title": "Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
    "published": 1716349620,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 67.18000030517578,
      "2024-05-22T14:30:00+00:00": 67.69999694824219,
      "2024-05-22T15:30:00+00:00": 67.5199966430664,
      "2024-05-22T16:30:00+00:00": 67.71050262451172,
      "2024-05-22T17:30:00+00:00": 67.84500122070312,
      "2024-05-22T18:30:00+00:00": 67.63999938964844,
      "2024-05-22T19:30:00+00:00": 67.43000030517578
    },
    "sentiment": 0.9133905172348022
  },
  {
    "title": "Gilead Sciences Hosts Inaugural Global Health Equity Summit",
    "published": 1716283020,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 67.79000091552734,
      "2024-05-21T14:30:00+00:00": 67.30010223388672,
      "2024-05-21T15:30:00+00:00": 67.0,
      "2024-05-21T16:30:00+00:00": 67.12999725341797,
      "2024-05-21T17:30:00+00:00": 66.88159942626953,
      "2024-05-21T18:30:00+00:00": 67.20989990234375,
      "2024-05-21T19:30:00+00:00": 67.35990142822266
    },
    "sentiment": 0.8800950050354004
  },
  {
    "title": "Gilead's Recently Acquired Liver Disease Candidate Shows Improvements In Disease Progression And Associated Itch",
    "published": 1716219376,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 67.70999908447266,
      "2024-05-20T14:30:00+00:00": 67.69860076904297,
      "2024-05-20T15:30:00+00:00": 67.69000244140625,
      "2024-05-20T16:30:00+00:00": 67.66000366210938,
      "2024-05-20T17:30:00+00:00": 67.95999908447266,
      "2024-05-20T18:30:00+00:00": 67.93000030517578,
      "2024-05-20T19:30:00+00:00": 67.94999694824219
    },
    "sentiment": 0.9486587643623352
  },
  {
    "title": "Gilead touts additional data on liver disease asset seladelpar ahead of PDUFA date",
    "published": 1716205200,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 67.70999908447266,
      "2024-05-20T14:30:00+00:00": 67.69860076904297,
      "2024-05-20T15:30:00+00:00": 67.69000244140625,
      "2024-05-20T16:30:00+00:00": 67.66000366210938,
      "2024-05-20T17:30:00+00:00": 67.95999908447266,
      "2024-05-20T18:30:00+00:00": 67.93000030517578,
      "2024-05-20T19:30:00+00:00": 67.94999694824219
    },
    "sentiment": 0.9018665552139282
  },
  {
    "title": "Seladelpar\u2019s Efficacy in PBC and Strategic Acquisition by Gilead Prompt Buy Rating",
    "published": 1716188160,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 67.70999908447266,
      "2024-05-20T14:30:00+00:00": 67.69860076904297,
      "2024-05-20T15:30:00+00:00": 67.69000244140625,
      "2024-05-20T16:30:00+00:00": 67.66000366210938,
      "2024-05-20T17:30:00+00:00": 67.95999908447266,
      "2024-05-20T18:30:00+00:00": 67.93000030517578,
      "2024-05-20T19:30:00+00:00": 67.94999694824219
    },
    "sentiment": 0.689149022102356
  },
  {
    "title": "Biopharma M&A surges year over year in Q1",
    "published": 1716080640,
    "day_prices": {},
    "sentiment": 0.924852192401886
  },
  {
    "title": "Private Equity Prowl: 3 Overlooked Stocks Primed for Buyout Bids",
    "published": 1715947560,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 67.7699966430664,
      "2024-05-17T14:30:00+00:00": 67.36060333251953,
      "2024-05-17T15:30:00+00:00": 67.5999984741211,
      "2024-05-17T16:30:00+00:00": 67.67500305175781,
      "2024-05-17T17:30:00+00:00": 67.69999694824219,
      "2024-05-17T18:30:00+00:00": 67.53500366210938,
      "2024-05-17T19:30:00+00:00": 67.52999877929688
    },
    "sentiment": 0.6810756921768188
  },
  {
    "title": "Guild Esports Signs Tekken Pro, Eyes Esports Cup",
    "published": 1715824740,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 67.01000213623047,
      "2024-05-16T14:30:00+00:00": 67.5250015258789,
      "2024-05-16T15:30:00+00:00": 67.74500274658203,
      "2024-05-16T16:30:00+00:00": 67.87680053710938,
      "2024-05-16T17:30:00+00:00": 67.80000305175781,
      "2024-05-16T18:30:00+00:00": 67.70999908447266,
      "2024-05-16T19:30:00+00:00": 67.7249984741211
    },
    "sentiment": 0.9315133094787598
  },
  {
    "title": "Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival",
    "published": 1717157614,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.6445696949958801
  },
  {
    "title": "Gilead\u2019s Trodelvy misses goal in bladder cancer study",
    "published": 1717153260,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.5098379254341125
  },
  {
    "title": "Gilead\u2019s Phase III urothelial cancer trial fails to meet primary endpoint",
    "published": 1717143922,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.9239128828048706
  },
  {
    "title": "Gilead to present EVOKE-01 study data at ASCO meeting",
    "published": 1717140480,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.9348657131195068
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS) and Gilead Sciences (GILD)",
    "published": 1717138260,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.8988000750541687
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Gilead Sciences (GILD) and Sanofi (OtherSNYNF)",
    "published": 1717131120,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.9022720456123352
  },
  {
    "title": "Hold Rating on Gilead Sciences Amid Trodelvy Trial Setbacks and Future Uncertainties",
    "published": 1717130820,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.9482693672180176
  },
  {
    "title": "Catalyst Watch: Nvidia stock split buzz, COMPUTEX, Walmart's annual meeting, and REITs on display",
    "published": 1717120980,
    "day_prices": {
      "2024-05-31T13:30:00+00:00": 62.69179916381836,
      "2024-05-31T14:30:00+00:00": 63.790000915527344,
      "2024-05-31T15:30:00+00:00": 63.22999954223633,
      "2024-05-31T16:30:00+00:00": 63.345001220703125,
      "2024-05-31T17:30:00+00:00": 63.54999923706055,
      "2024-05-31T18:30:00+00:00": 63.81999969482422,
      "2024-05-31T19:30:00+00:00": 64.04000091552734
    },
    "sentiment": 0.9244752526283264
  },
  {
    "title": "Gilead Provides Update on Phase 3 TROPiCS-04 Study",
    "published": 1717101900,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 63.47999954223633,
      "2024-05-30T14:30:00+00:00": 63.415000915527344,
      "2024-05-30T15:30:00+00:00": 63.739898681640625,
      "2024-05-30T16:30:00+00:00": 63.60499954223633,
      "2024-05-30T17:30:00+00:00": 64.29000091552734,
      "2024-05-30T18:30:00+00:00": 64.05329895019531,
      "2024-05-30T19:30:00+00:00": 64.13999938964844
    },
    "sentiment": 0.9336373209953308
  },
  {
    "title": "Gilead Sciences urged to share new \"game-changer\" HIV drug",
    "published": 1717078380,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 63.47999954223633,
      "2024-05-30T14:30:00+00:00": 63.415000915527344,
      "2024-05-30T15:30:00+00:00": 63.739898681640625,
      "2024-05-30T16:30:00+00:00": 63.60499954223633,
      "2024-05-30T17:30:00+00:00": 64.29000091552734,
      "2024-05-30T18:30:00+00:00": 64.05329895019531,
      "2024-05-30T19:30:00+00:00": 64.13999938964844
    },
    "sentiment": 0.7027914524078369
  },
  {
    "title": "Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB) and Argenx Se (ARGX)",
    "published": 1717063260,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 63.47999954223633,
      "2024-05-30T14:30:00+00:00": 63.415000915527344,
      "2024-05-30T15:30:00+00:00": 63.739898681640625,
      "2024-05-30T16:30:00+00:00": 63.60499954223633,
      "2024-05-30T17:30:00+00:00": 64.29000091552734,
      "2024-05-30T18:30:00+00:00": 64.05329895019531,
      "2024-05-30T19:30:00+00:00": 64.13999938964844
    },
    "sentiment": 0.7460070848464966
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Integer Holdings (ITGR), Gilead Sciences (GILD) and Centene (CNC)",
    "published": 1717050120,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 63.47999954223633,
      "2024-05-30T14:30:00+00:00": 63.415000915527344,
      "2024-05-30T15:30:00+00:00": 63.739898681640625,
      "2024-05-30T16:30:00+00:00": 63.60499954223633,
      "2024-05-30T17:30:00+00:00": 64.29000091552734,
      "2024-05-30T18:30:00+00:00": 64.05329895019531,
      "2024-05-30T19:30:00+00:00": 64.13999938964844
    },
    "sentiment": 0.9185407161712646
  },
  {
    "title": "Gilead says Phase 3 TROPiCS-04 study did not meet primary endpoint",
    "published": 1717040940,
    "day_prices": {
      "2024-05-30T13:30:00+00:00": 63.47999954223633,
      "2024-05-30T14:30:00+00:00": 63.415000915527344,
      "2024-05-30T15:30:00+00:00": 63.739898681640625,
      "2024-05-30T16:30:00+00:00": 63.60499954223633,
      "2024-05-30T17:30:00+00:00": 64.29000091552734,
      "2024-05-30T18:30:00+00:00": 64.05329895019531,
      "2024-05-30T19:30:00+00:00": 64.13999938964844
    },
    "sentiment": 0.9067828059196472
  },
  {
    "title": "Gilead and Cartography enter deal to develop cancer therapies",
    "published": 1716977159,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 63.5,
      "2024-05-29T14:30:00+00:00": 63.209999084472656,
      "2024-05-29T15:30:00+00:00": 63.380001068115234,
      "2024-05-29T16:30:00+00:00": 63.339900970458984,
      "2024-05-29T17:30:00+00:00": 63.345001220703125,
      "2024-05-29T18:30:00+00:00": 63.380001068115234,
      "2024-05-29T19:30:00+00:00": 63.47999954223633
    },
    "sentiment": 0.623114287853241
  },
  {
    "title": "Is Nvidia Worth 35x Times Sales, History Says No",
    "published": 1716946980,
    "day_prices": {
      "2024-05-29T13:30:00+00:00": 63.5,
      "2024-05-29T14:30:00+00:00": 63.209999084472656,
      "2024-05-29T15:30:00+00:00": 63.380001068115234,
      "2024-05-29T16:30:00+00:00": 63.339900970458984,
      "2024-05-29T17:30:00+00:00": 63.345001220703125,
      "2024-05-29T18:30:00+00:00": 63.380001068115234,
      "2024-05-29T19:30:00+00:00": 63.47999954223633
    },
    "sentiment": 0.7977768778800964
  },
  {
    "title": "2 Beaten-Down Dividend Stocks to Buy and Hold For 10 Years",
    "published": 1716903900,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 65.25,
      "2024-05-28T14:30:00+00:00": 64.86000061035156,
      "2024-05-28T15:30:00+00:00": 64.63999938964844,
      "2024-05-28T16:30:00+00:00": 64.27100372314453,
      "2024-05-28T17:30:00+00:00": 64.02999877929688,
      "2024-05-28T18:30:00+00:00": 63.96500015258789,
      "2024-05-28T19:30:00+00:00": 63.819000244140625
    },
    "sentiment": 0.909073531627655
  },
  {
    "title": "Gilead partnering with Cartography Biosciences to discover cancer therapies",
    "published": 1716888420,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 65.25,
      "2024-05-28T14:30:00+00:00": 64.86000061035156,
      "2024-05-28T15:30:00+00:00": 64.63999938964844,
      "2024-05-28T16:30:00+00:00": 64.27100372314453,
      "2024-05-28T17:30:00+00:00": 64.02999877929688,
      "2024-05-28T18:30:00+00:00": 63.96500015258789,
      "2024-05-28T19:30:00+00:00": 63.819000244140625
    },
    "sentiment": 0.6644406318664551
  },
  {
    "title": "G1 Therapeutics slips after new breast cancer data for lead asset",
    "published": 1716860280,
    "day_prices": {
      "2024-05-28T13:30:00+00:00": 65.25,
      "2024-05-28T14:30:00+00:00": 64.86000061035156,
      "2024-05-28T15:30:00+00:00": 64.63999938964844,
      "2024-05-28T16:30:00+00:00": 64.27100372314453,
      "2024-05-28T17:30:00+00:00": 64.02999877929688,
      "2024-05-28T18:30:00+00:00": 63.96500015258789,
      "2024-05-28T19:30:00+00:00": 63.819000244140625
    },
    "sentiment": 0.9477910995483398
  },
  {
    "title": "Unloved Gilead Due For Reversal On Flight-To-Safety Money Flows",
    "published": 1716814140,
    "day_prices": {},
    "sentiment": 0.9099150896072388
  },
  {
    "title": "Wall Street Breakfast: The Week Ahead",
    "published": 1716710748,
    "day_prices": {},
    "sentiment": 0.9028444886207581
  },
  {
    "title": "Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo",
    "published": 1716629100,
    "day_prices": {},
    "sentiment": 0.9204940795898438
  },
  {
    "title": "Catalyst Watch: Costco earnings, M&A drama, Viking ratings, and a key inflation read",
    "published": 1716516240,
    "day_prices": {
      "2024-05-24T13:30:00+00:00": 66.30000305175781,
      "2024-05-24T14:30:00+00:00": 65.83499908447266,
      "2024-05-24T15:30:00+00:00": 65.63999938964844,
      "2024-05-24T16:30:00+00:00": 65.2699966430664,
      "2024-05-24T17:30:00+00:00": 65.41000366210938,
      "2024-05-24T18:30:00+00:00": 65.4749984741211,
      "2024-05-24T19:30:00+00:00": 65.33999633789062
    },
    "sentiment": 0.9077320694923401
  }
]